Flagship explainer
What drives PURE Bioscience, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$2.4M | FY2025 |
| |
| Income before tax | −$2.4M | FY2025 |
|
| Operating income | −$2.3M | FY2025 |
|
| $2.2M | FY2025 |
| |
| Ending assets | $1.1M | FY2025 |
|
| Beginning assets | $818000 | FY2024 |
|
| −$5.1M | FY2025 |
| |
| −$2.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001493152-25-020065